Immunetics, Inc. is a company that develops and markets diagnostic tests and assays for infectious diseases like bacterial, viral and parasitic infections. Some of its key products include tests for Lyme disease, bacterial contamination of platelets, and emerging infections like Babesiosis and Chagas disease. The company is developing new tests for HIV, fungal infections, and SARS. It has a pipeline of diagnostic products in various stages of development. Immunetics markets its products worldwide through distributors and is headquartered in Boston. This report provides an analysis of Immunetics' product pipeline, including details on each pipeline product, development status, milestones, and market potential.